Cargando…
ADAM10 and ADAM17 as Biomarkers Linked to Inflammation, Metabolic Disorders and Colorectal Cancer
ADAM10 and ADAM17 have a role in inflammation and diseases associated with inflammation, such as diabetes, cardiovascular diseases (CVD) or cancer, e.g., colorectal cancer (CRC). The aim of this study was to evaluate whether ADAM10 and ADAM17 could be biomarkers of CRC. To achieve this goal, CRC tum...
Autores principales: | Sikora-Skrabaka, Magdalena, Walkiewicz, Katarzyna Weronika, Nowakowska-Zajdel, Ewa, Waniczek, Dariusz, Strzelczyk, Joanna Katarzyna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600049/ https://www.ncbi.nlm.nih.gov/pubmed/36286024 http://dx.doi.org/10.3390/cimb44100309 |
Ejemplares similares
-
Role of Some microRNA/ADAM Proteins Axes in Gastrointestinal Cancers as a Novel Biomarkers and Potential Therapeutic Targets—A Review
por: Kalita, Agnieszka, et al.
Publicado: (2023) -
The role of some ADAM-proteins and activation of the insulin growth factor-related pathway in colorectal cancer
por: Walkiewicz, Katarzyna, et al.
Publicado: (2018) -
Adamalysines as Biomarkers and a Potential Target of Therapy in Colorectal Cancer Patients: Preliminary Results
por: Walkiewicz, Katarzyna, et al.
Publicado: (2019) -
Clinical Significance and Prognostic Relevance of Microsatellite Instability in Sporadic Colorectal Cancer Patients
por: Copija, Angelika, et al.
Publicado: (2017) -
Evaluation of Malondialdehyde Level, Total Oxidant/Antioxidant Status and Oxidative Stress Index in Colorectal Cancer Patients
por: Janion, Karolina, et al.
Publicado: (2022)